лекови.мкСпоредбени цени на лековите на големо во референтните земји

Патот на парите за лековиThe path of money for medicines

Од буџетот на државата до болницата и аптекатаFrom the state budget to the hospital and the pharmacy

ГодинаYear2025
1БУЏЕТ НА ДРЖАВАТАSTATE BUDGET6,56 милијарди евра6.56 billion euros403,7 милијарди денари, план по ребаланс403.7 billion denars, revised plan2ФОНД И МИНИСТЕРСТВО ЗА ЗДРАВСТВОFUND AND MINISTRY OF HEALTH897 милиони евра897 million eurosФонд 837 · Министерство за здравство 60Fund 837 · Ministry of Health 60▼ 13,7% од буџетот13.7% of the budget3ЛЕКОВИ, СИТЕ ИЗВОРИMEDICINES, ALL SOURCES213 милиони евра213 million euros117 евра по жител117 euros per inhabitant▼ 23,7% од здравството23.7% of health4КАНАЛИCHANNELS3 канали3 channelsболници 53% · аптеки 27% · програми 20%hospitals 53% · pharmacies 27% · programmes 20%5БОЛНИЦИHOSPITALS112 милиони евра112 million euros93 установи · 1.514 договори93 institutions · 1,514 contracts6АПТЕКИPHARMACIES58,5 милиони евра58.5 million euros1.207 аптеки · 27,3 милиони рецепти1,207 pharmacies · 27.3 million prescriptions
  • 42 милиони €€42 millionпрограми на Министерството: ретки болести, инсулин, вакциниMinistry programmes: rare diseases, insulin, vaccines
  • 123веледрогерии со дејност лековиwholesalers active in medicines
  • 102 милиони €€102 millionдостасани долгови на јавните установиoverdue debts of public institutions
  • 46%од болничките лекови се цитостатициof hospital medicines are cancer medicines

Ви треба истата слика за вашата молекула, вашата терапевтска група или вашите конкуренти?Need the same picture for your molecule, your therapeutic group or your competitors?

Подготвуваме детални извештаи по нарачка од истите бази на податоци. Секој извештај се прилагодува на потребите на компанијата: опфат, период и ниво на детал.We prepare detailed custom reports from the same databases. Each report is tailored to the company's needs: scope, period and level of detail.

  • Тендери по молекула: цени, количини, понудувачиTenders by molecule: prices, volumes, bidders
  • Конкурентски преглед по терапевтска групаCompetitor review by therapeutic group
  • Трошоци на Фондот и условни буџетиFund spending and conditional budgets
  • Профил на установа: набавки, долгови, рокови на плаќањеInstitution profile: purchasing, debts, payment times
  • Дистрибутивна мрежа: веледрогерии и аптекиDistribution network: wholesalers and pharmacies

Извори: Буџет на Република Северна Македонија за 2025 (ребаланс); Фонд за здравствено осигурување, извештаи за 2025; Завршна сметка на Буџетот за 2025; e-nabavki.gov.mk; регистри на Агенцијата за лекови (ноември 2026). Министерството е прикажано без трансферот кон Фондот. Курс 61,5 денари за едно евро.Sources: Budget of the Republic of North Macedonia for 2025 (revised); Health Insurance Fund, 2025 reports; Final account of the 2025 Budget; e-nabavki.gov.mk; registers of the Agency for Medicines (November 2026). The Ministry is shown without its transfer to the Fund. Rate 61.5 denars per euro.

Insights

Pricing methodology for medicines

Mapped to the Methodology on the manner of forming the prices of medicines (Government of the Republic of North Macedonia, No. 45-4259/1 of 4 July 2019, consolidated text), adopted under Article 108(10) of the Law on Medicines and Medical Devices.

Reference countries and data sources (Art. 4)

The reference countries are Slovenia, Bulgaria, Croatia, Serbia and Greece. The comparison uses the latest official wholesale price data published by the competent authorities of those countries. If a comparison price cannot be established in any, or in only one, of the five countries, all EU member states serve as reference countries; if the medicine is not authorized in any EU member state, the price in the manufacturer's country applies.

For North Macedonia two official sources are shown side by side: the current wholesale price from the medicines price register, and the maximum wholesale price excluding VAT set by the Ministry of Health in the maximum-price register (shown as “max.” under the Macedonian price, with the ATC code taken from the same register). The difference between the two is the headroom the holder has under the regulated ceiling.

Price basis and the "same medicine" (Art. 5–8)

Comparison is made at the wholesale price level, excluding VAT. The same medicine means the same INN, pharmaceutical form, strength and pack (Art. 6); the comparison price is established separately for each form, strength and pack (Art. 8). Where the same form is absent, related forms may be compared (e.g. tablet – coated tablet – capsule; suspension – syrup – solution), except that prolonged or modified release forms cannot be equated with non-modified forms. Where pack sizes differ, the closest pack is used and the comparison price is calculated per unit and scaled to the pack in question (Art. 7).

Country comparison price — generics (Art. 9)

Comparison price per country = average of all wholesale prices in that country with the same INN, form, strength and pack, from different manufacturers

Maximum wholesale price (Art. 11)

Maximum wholesale price in RNM = ( C₁ + C₂ ) / 2
where C₁ and C₂ are the two lowest country comparison prices

If a comparison price exists in only one reference country, the average is taken of that price and the lowest price across all EU member states (Art. 11(3)). Where no comparison price exists at all, the maximum wholesale price derives from the import price plus customs, import costs and wholesale margin, capped at 25% (import price up to EUR 10), 20% (over EUR 10.01) or 15% (over EUR 100.01) of the import price (Art. 11(5)).

Originator medicines (Art. 17)

Maximum wholesale price of the originator = average of the two lowest wholesale prices of the originator's own product (same manufacturer) in the reference countries

Biosimilars are priced at no more than 85% of the maximum wholesale price of the corresponding biological medicine; parallel imports at no more than 85% of the formed price of the same or similar authorized medicine (Art. 15, 15-a).

Currency conversion (Art. 10)

Comparison prices in foreign currency are converted to denars at the National Bank of RNM middle exchange rate applicable on the last 1 March preceding the calculation date.

Annual revision (Art. 12)

The Ministry of Health determines the maximum wholesale price once per year on 15 March and publishes it at lekovi.zdravstvo.gov.mk. The MAH is notified of the proposed calculation in advance and may submit objections; a request for price formation must follow within seven days of the determination, failing which the previously formed price ceases to be valid. The newly determined maximum price cannot exceed the existing maximum price (Art. 12(6)).

Retail margins (Art. 14)

  • Wholesale price up to EUR 5.00 — retail margin 28%
  • EUR 5.01 to 20.00 — margin 25%
  • EUR 20.01 to 100.00 — margin 20%
  • Above EUR 100.01 — fixed margin of MKD 1,200

How this tool applies the methodology

The calculation panel in the search view computes, from the currently filtered results: the country comparison price per Art. 9 (generic mode: average of all matching prices per country) or per Art. 17 (originator mode: the originator product's price per country); the maximum wholesale price per Art. 11 as the average of the two lowest country values; and an indicative retail price excluding VAT per the Art. 14 margin bands.

Analyst responsibility: the computed figures are valid only when the result set is filtered to a single INN, pharmaceutical form, strength and comparable pack (Art. 6, 8) — and, in originator mode, to the originator's brand. Per-unit scaling for non-identical packs (Art. 7) and the Art. 10 exchange rate cut-off must be applied by the analyst. Derived figures are analytical indications, not administrative decisions.

Побарајте детален извештајRequest a detailed report

Означете што ве интересира. Ќе ви одговориме со предлог за опфат, рок и цена.Mark what interests you. We will reply with a proposed scope, timing and price.